Could umbilical cord stem cells repair damaged livers?

NCT ID NCT07413549

Recruiting now Disease control Sponsor: Beijing Tuohua Weiye Biotechnology Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether stem cells from umbilical cords can safely help people with severe liver scarring caused by hepatitis B. The trial involves 76 adults who will receive the stem cells through a vein. Researchers will check for side effects and measure if liver function improves.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

human umbilical cord mesenchymal stem cells

What this could lead to

If it works, this could offer a new way to improve liver function and reduce complications in people with advanced hepatitis B cirrhosis.

What could go wrong

This is an early phase 1-2 trial with only 76 participants, so results may not apply broadly. Stem cell treatments carry risks like infection or immune reactions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates